Find information and resources about the Research Institute's COVID-19 response
HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Maxwell Chappell is a graduate student working on developing improved lentiviral vectors as well as the use of lentiviral vectors for the treatment of alpha-thalassemia.
The Rivella Laboratory uses lentiviral vectors for modulation of gene expression and gene transfer for the cure of hemoglobinopathies.
Pioneering new approaches to diagnosis, care, and treatment for patients with red blood cell disorders with novel gene therapies and stem-cell-based treatments that aim to reduce symptoms and prolong life.